Jesse McGreivy is joining Adicet Bio to become the Menlo Park, CA, company’s chief medical officer. McGreivy most recently served as chief medical officer at Redwood City, CA, cancer drug developer Acerta Pharma. His experience also includes posts at Pharmacyclics (NASDAQ: [[ticker:PCYC]]) and Amgen (NASDAQ: [[ticker:AMGN]]). Adicet is developing immunotherapies for cancer and other diseases.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
